Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Immuron Reported Q1 Sales Growth Of 34% On Prior Comparative Period

Author: Benzinga Newsdesk | October 13, 2025 05:07am

Sales Highlights (unaudited):

Global

 
Q1 sales AUD$2.0 million up 34% on prior comparative period (pcp)
Australia

 


 
Q1 sales AUD$1.6 million up 52% on pcp
Canada

 
Q1 sales AUD$0.0 million down 92% on pcp
USA

 


 
Q1 sales AUD$0.4 million up 44% on pcp

Posted In: IMRN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist